CTLA4 and neoplasm: In both immunograms of all patients (Figure S2A) and chemotherapy patients specifically (Figure S2B), glycolysis and recognition of tumor cells exhibited the highest scores, while immune checkpoints and anti-CTLA4 resistance MAGE gene (CRMA) signature demonstrated the lowest.